APA (7th ed.) Citation

T, W., ML, v. d. B., V, K., ISE, W., MJAP, D., RA, B., . . . AY, N. (2025). Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis. British journal of pharmacology, 182(18), 4221. https://doi.org/10.1111/bph.17374

Chicago Style (17th ed.) Citation

T, Woudenberg, van der Bent ML, Kremer V, Waas ISE, Daemen MJAP, Boon RA, Quax PHA, and Nossent AY. "Site-specific M6A-miR-494-3p, Not Unmethylated MiR-494-3p, Compromises Blood Brain Barrier by Targeting Tight Junction Protein 1 in Intracranial Atherosclerosis." British Journal of Pharmacology 182, no. 18 (2025): 4221. https://doi.org/10.1111/bph.17374.

MLA (9th ed.) Citation

T, Woudenberg, et al. "Site-specific M6A-miR-494-3p, Not Unmethylated MiR-494-3p, Compromises Blood Brain Barrier by Targeting Tight Junction Protein 1 in Intracranial Atherosclerosis." British Journal of Pharmacology, vol. 182, no. 18, 2025, p. 4221, https://doi.org/10.1111/bph.17374.